Avinger, Inc. Stock

Equities

AVGR

US0537348775

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-06-07 pm EDT 5-day change 1st Jan Change
1.96 USD +1.02% Intraday chart for Avinger, Inc. -8.63% -27.68%
Sales 2024 * 10.5M Sales 2025 * 13.93M Capitalization 3.34M
Net income 2024 * -16M Net income 2025 * -14M EV / Sales 2024 * 0.32 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.24 x
P/E ratio 2024 *
-0.06 x
P/E ratio 2025 *
-0.1 x
Employees 70
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.02%
1 week-8.63%
Current month-8.63%
1 month-47.88%
3 months-40.61%
6 months-35.74%
Current year-27.68%
More quotes
1 week
1.75
Extreme 1.75
2.43
1 month
1.75
Extreme 1.75
4.15
Current year
1.75
Extreme 1.75
5.45
1 year
1.75
Extreme 1.75
18.00
3 years
1.75
Extreme 1.75
438.00
5 years
1.75
Extreme 1.75
1 560.00
10 years
1.75
Extreme 1.75
1 000 000.00
More quotes
Managers TitleAgeSince
Founder 63 07-03-07
Chief Executive Officer 61 14-12-28
Director of Finance/CFO 41 19-12-31
Members of the board TitleAgeSince
Chief Executive Officer 61 14-12-28
Chairman 81 14-11-30
Director/Board Member 72 11-02-28
More insiders
Date Price Change Volume
24-06-07 1.96 +1.02% 21,830
24-06-06 1.94 -4.43% 31,385
24-06-05 2.03 +7.41% 29,387
24-06-04 1.89 -10.85% 60,326
24-06-03 2.12 -1.17% 26,331

Delayed Quote Nasdaq, June 07, 2024 at 04:30 pm EDT

More quotes
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.96 USD
Average target price
5 USD
Spread / Average Target
+155.13%
Consensus